Divi's Laboratories vs Torrent Pharma: share price, P/E, ROE and financials compared
Divi's Laboratories
Torrent Pharmaceuticals
Divi's Laboratories and Torrent Pharma at a glance
Divi's Laboratories and Torrent Pharma are both listed in Healthcare. Divi's Laboratories is the larger by market cap, at ₹2.7L Cr against ₹1.8L Cr for Torrent Pharma (1.5 times as large). On valuation, Torrent Pharma has the lower P/E (80.2× against 93.6×) and the lower price-to-book (9.83× against 16.35×). On returns and margins, Divi's Laboratories has the higher ROCE (19.0% against 9.1%), the higher ROE (16.2% against 15.7%) and the higher operating margin (34.9% against 33.7%). Over three years, Torrent Pharma has faster 3-year sales growth (+13.3% against +11.0% a year) and faster 3-year profit growth (+20.2% against +12.1% a year). Divi's Laboratories carries less debt for its equity, with a debt-to-equity of 0.00× against 0.77×.
Key metrics, side by side
| Metric | Divi's LaboratoriesDIVISLAB | Torrent PharmaTORNTPHARM |
|---|---|---|
| Price (₹) | 10,320.50 | 4,750.00 |
| Market cap (₹ Cr) | 2,73,977 | 1,80,675 |
| P/E | 93.6× | 80.2× (the lower figure, shaded) |
| P/B | 16.35× | 9.83× (the lower figure, shaded) |
| Dividend yield, trailing | 0.29% | 0.80% (the higher figure, shaded) |
| ROE | 16.2% (the higher figure, shaded) | 15.7% |
| ROCE | 19.0% (the higher figure, shaded) | 9.1% |
| Operating margin (OPM) | 34.9% (the higher figure, shaded) | 33.7% |
| Net margin (NPM) | 26.0% (the higher figure, shaded) | 12.2% |
| Sales CAGR 3Y | +11.0% | +13.3% (the higher figure, shaded) |
| Profit CAGR 3Y | +12.1% | +20.2% (the higher figure, shaded) |
| Debt to equity | 0.00× (the lower figure, shaded) | 0.77× |
| Interest cover | 148.3× (the higher figure, shaded) | 8.5× |
| Net profit TTM (₹ Cr) | – | 2,124 |
| 1Y return | +49.0% (the higher figure, shaded) | +31.7% |
| Promoter holding | 51.88% | 60.78% |
Divi's Laboratories vs Torrent Pharma: common questions
Which is bigger, Divi's Laboratories or Torrent Pharma?
By market cap, Divi's Laboratories is bigger at ₹2.7L Cr, against ₹1.8L Cr for Torrent Pharma (prices as of 6 Nov 2026).
Which has a lower P/E ratio, Divi's Laboratories or Torrent Pharma?
Divi's Laboratories trades at a P/E of 93.6× and Torrent Pharma at 80.2×. Torrent Pharma has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Divi's Laboratories or Torrent Pharma?
Divi's Laboratories reports a return on equity of 16.2% and Torrent Pharma 15.7%. Divi's Laboratories has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Divi's Laboratories or Torrent Pharma?
Over the last three years: Sales grew +11.0% a year at Divi's Laboratories and +13.3% at Torrent Pharma, so Torrent Pharma grew sales faster; profit grew +12.1% a year at Divi's Laboratories and +20.2% at Torrent Pharma, so Torrent Pharma grew profit faster. Past growth doesn’t predict future growth.